Background-Intima-media thickness (IMT) of the common and internal carotid arteries is an established surrogate for atherosclerosis and predicts risk of stroke and myocardial infarction. Often IMT is measured as the average of these 2 arteries; yet, they are believed to result from separate biological mechanisms. The aim of this study was to conduct a family-based genome-wide association study (GWAS) for IMT to identify polymorphisms influencing IMT and to determine if distinct carotid artery segments are influenced by different genetic components.
T he identification of genes that influence complex diseases, such as atherosclerosis and stroke, is difficult because of several interacting risk factors contributing to their manifestation in adulthood. The study of quantitative risk factors, such as carotid intima-media thickness (IMT), provides a powerful approach on the elucidation of genetic components preceding clinical disease onset. Currently, case/control genomewide association studies (GWAS) are the most widely used approach to associate genetic variation with phenotypic diversity. These studies have identified several common genetic variants, increasing our understanding of genetic components underlying common chronic diseases. However, this approach is limited in its ability to determine genetic associations across populations or account for the majority of the heritable components in complex traits and rare variants. 1 The focus on cases and controls also neglects information about degree of severity among cases and degree of risk among controls. Alternatively, family-based association studies and studies of quantitative phenotypes are better powered to detect underlying genetic determinants that may have a larger effect on phenotypic diversity. 2 Therefore, the use of risk factors and family data within GWAS may allow for the detection of novel genetic components influencing IMT.
Clinical Perspective on p 221
IMT of the common and internal carotid arteries determined through B-mode ultrasonography is a quantitative measure of atherosclerosis and a strong predictor of future cardiovascular disease (CVD) and stroke. 3, 4 Differences in the prevalence and severity of CVD between ethnicities are known to occur and corresponding disparities in IMT have been reported. 5, 6 There is no consensus on which carotid arterial site serves as the best proxy of clinical cardiovascular outcomes. However, 1 previous study using the Framingham Offspring Cohort found that although both internal and common carotid artery maximum IMT were significant predictors of CVD outcome, only internal carotid maximum IMT improved CVD risk classification. 7 Each carotid artery segment has a different anatomy and may, therefore, be influenced by different risk pathways. 8 IMT variation has been suggested to be higher for the near wall (nearest the skin and the ultrasound transducer) than for the far wall, because of characteristics of transmission and ultrasound beam reflection. 9 Although additional risk factors and IMT progression rates for both arterial segments are similar, 10 there are competing hypotheses on the cardiovascular biology that each of these impacts. Research has suggested that IMT of the common carotid artery is representative of total atherosclerotic burden, whereas IMT of the internal carotid artery is a response to local turbulent hemodynamic flow. 8 Therefore, it is probable that each carotid artery segment may be influenced by unique genetic components acting in combination to influence the complex pathogenesis of atherosclerosis development. 11 However, there may also be common genetic influences on near and far wall thickness, and these may be better detected with composite measures, such as the average of the near and far walls.
The heritability of carotid IMT ranges from 0.09 to 0.40; 12 yet, the genetic variants affecting IMT remain unidentified. Three previous studies have investigated genetic association for common carotid artery phenotypes in specific genomic regions for populations of Hispanic descent; [13] [14] [15] however, there is no previous GWAS available for Mexican Americans. Four previous GWAS investigated genetic association involving IMT [16] [17] [18] [19] ; only 1 produced genome-wide significant results after correction for multiple testing 19 and these findings have not been replicated. A recent meta-analysis of 9 European cohorts and >30 000 individuals detected 5 genomic regions (4q31, 7q22, 8q23, 8q24, and 19q13) associated with common carotid artery phenotypes or carotid artery plaque. 20 To explore genetic determinants of IMT and subclinical atherosclerosis, we conducted a GWAS using 913 219 single-nucleotide polymorphisms (SNPs) in 772 Mexican American participants from the San Antonio Family Heart Study (SAFHS). The objective of this study is to identify SNPs impacting 6 IMT phenotypes: (1) average of near and far wall measures (cIMT), (2) near (cnwIMT), and (3) far (cfwIMT) walls of the common carotid artery, (4) average of near and far walls (iIMT), (5) near (inwIMT), and (6) far (ifwIMT) walls of the internal carotid artery. We also sought to determine if previously identified genomic regions associated with either common or internal artery IMT can be replicated in a densely mapped GWAS. This study represents the first GWAS of IMT in a non-European population.
Materials and Methods

San Antonio Family Heart Study
The SAFHS includes 1431 individuals in 42 extended Mexican American families. This analysis was limited to 772 individuals in 29 families who participated in the second SAFHS examination between 1996 and 1999 who had B-mode ultrasound information available. 21 SAFHS probands were 40-to 60-year-old men and women recruited without regard to disease status residing in San Antonio, Texas who had a living spouse and at least 6 first-degree relatives aged >16 years. The SAFHS second examination included interviews, blood pressure measurements, anthropometrics, fasting venipuncture, and an oral glucose tolerance test. Measurements of blood pressures, body mass index, fasting total and high-density lipoprotein cholesterol, and fasting triglyceride have been previously described. 21
Intima-Media Thickness Measurement
B-Mode ultrasound evaluations were completed on bilateral segments of extracranial carotid arteries applying protocols identical to those in the Cardiovascular Health Study. 22 Ultrasound images were recorded on super-video home system tapes and sent monthly to central carotid ultrasound readers, where 1 reader reads each participant's image. The scanning protocol required sonographers to obtain, on the right and left sides, 1 lateral view of the common carotid artery and 3 views of the internal carotid artery in different fixed planes. The common carotid artery was defined as the 10-mm segment of the carotid artery immediately proximal to the origin of the bulb, where the near and far walls of the artery were parallel. Three views of internal carotid artery segments were centered on the site of maximum wall thickness within the carotid artery bulb or where the sonographer considered the artery to be normal (without evidence of plaque) on the initial 10 mm of the arterial segment. Pulsed-wave Doppler was recorded at the point of maximum velocity in each carotid artery. Ultrasound readers measured the near and far wall IMT of common carotid view and 3 different views (near and far walls, plus carotid arterial plaque) of the internal carotid artery centered on sites of maximum thickness. 23 Measurements between the near and far walls for both the common and the internal carotid arteries were also averaged to provide a composite measure of each artery. The majority of previous IMT studies used this composite measure, so inclusion of this measure allows for cross-study comparisons of our results.
Genome-Wide Association Study
SNP genotypes were obtained using a combination of Illumina chips to generate a total of 1 000 929 SNPs; these included the HumanHap550v3 supplemented with the HumanExon510Sv1, Human1Mv1, and Human1M-Duov3 BeadChips. Genotype distributions were compared across arrays to identify potential batch effects. A total of 12 322 SNPs with low call rates (<0.95) were dropped; 38 692 SNPs were monoallelic; and 17 862 SNPs had <10 individuals carrying the minor allele and were eliminated. The remaining SNPs were then input to the program Sequential Oliogenic Linkage Analysis Routines 24 to compute maximum likelihood estimates for Hardy-Weinberg equilibrium (HWE). A total of 844 SNPs with HWE values with P<10e −4 were dropped, leaving 931 219 SNPs. SNP genotypes were checked for Mendelian consistency using Simwalk. 25 Merlin 26 was used to impute missing genotypes conditional on relatives' genotypes, with a weighted average of possible genotypes being used when an individual's genotype could not be inferred with certainty. The number of independent tests in the GWAS given the observed linkage disequilibrium (LD) between the SNPs was determined using Moskvina and Schmidt's 27 method in Sequential Oliogenic Linkage Analysis Routines 24 and, based on this, the threshold for genome-wide significant association was set at P<9.9e −8 and the threshold for suggestive association at P<5.0e −7 . Manhattan plots were constructed using the computer program R and regional plots using LocusZoom. 28
Statistical Analysis
Measured genotype association analyses were undertaken for 6 IMT phenotypes applying variance-component methods and implemented in Sequential Oliogenic Linkage Analysis Routines. 24 This method uses the kinship matrix to describe the variance/ covariance matrix of the subject's random effects. Covariates used in these analyses are shown in Table 1 . Variables were carried forward to association models if associated with IMT at P<0.05. Because variance components are sensitive to kurtosis, IMT phenotypes were transformed using Sequential Oliogenic Linkage Analysis Routines inverse normalization procedure. 24 To assess the relationship between phenotypes, we examined genetic and environmental correlations through joint polygenic analyses of both IMT arterial segments. 29 Genetic association was tested for each SNP under an additive genetic model allowing mean IMT to vary by the number of minor alleles. This model was compared with the null model of no difference in IMT by SNP genotype using a likelihood ratio test. Twice the difference in log-likelihoods of these models was distributed as a χ 2 random variable with 1 degree of freedom. We also examined SNPs, within or near 43 regions ( Table I in the online-only Data Supplement), previously associated with IMT 9,16-19,30 through candidate gene, linkage, or GWAS tests. To determine coverage for these 43 loci, we compared these SNPs with variants available in HapMap for European Americans from Utah (CEU; http://www. ncbi.nih.org). Taking into account LD between variants, we had coverage ranging from 17% for TGFB2 to 100% for 5 loci (APOE, CCR5, NOS3, PLAT, and REN), with an average coverage of 44% across all 43 loci ( Table I in the online-only Data Supplement). The R package princomp was used to run the principal components analysis on a subset of 11 512 autosomal SNPs (determined to be in low LD) in 345 genotyped SAFHS founders, and offspring was assigned PC values averaged over their parents, to not accidentally remove true pedigree differences. The first 4 principal components were included as covariates in all statistical analyses (these account for ≈3% of the variance in the genotype scores, indicating that there is little evidence for stratification in this Mexican American family-based cohort). This absence of stratification is further supported by quantile-quantile plots of the 6 investigated IMT phenotypes (Figure 1) , where the genomic inflation factor (λ) ranged from 1.00 for ifwIMT to 1.02 for cfwIMT.
Results
Clinical characteristics for the 772 SAFHS participants are presented in Table 1 . The mean age was 42.17 (±15.78 SD) years and 61% were women. Measurement variation for IMT was nearly identical for both carotid artery segments in the SAFHS. The average thicknesses for common carotid artery phenotypes ranged from 0.688 (±0.22 SD) mm for cfwIMT to 0.694 (±0.18 SD) mm for cnwIMT. The average value for cIMT was 0.691 (±0.20 SD) mm. For internal carotid arteries, average thickness for iIMT was 0.856 (±0.43 SD) mm and varied little between inwIMT, 0.857 (±0.43 SD) mm, and ifwIMT, 0.855 (±0.45 SD) mm. Heritabilities were significant for all 6 investigated phenotypes and are shown in Table 1 . Mean IMT increased with age and was higher in men than women for all 6 IMT phenotypes. However, other significant covariates differed between the internal and the common carotid arteries. Mean IMT was increased with elevated systolic blood pressure (SBP) and use of lipid medication for all the 3 common carotid artery phenotypes. Although presence of diabetes mellitus was associated with higher mean levels for all internal carotid artery phenotypes, use of lipid medication was associated with increased mean levels for 2 internal carotid artery phenotypes (iIMT and inwIMT), and tobacco use was associated with only 1 phenotype (ifwIMT). The genetic correlation (ρ) for the 2 separate internal carotid artery phenotypes (inwIMT and ifwIMT) was 0.99 (P=1.99e −18 ) and significantly different from 0, but not significantly different from 1, whereas for common carotid artery (cnwIMT and † †SD is given in brackets, unless percentage is indicated. ** P value <0.001 cfwIMT) measures, ρ=0.89 and was not significantly different from 0 or 1. The genetic correlation between iIMT and cIMT is 0.51 and was significantly different from both 0 (P=0.0011) and 1 (P=8.87e −5 ), which indicates that each arterial segment may be influenced by overlapping but not identical underlying genetic variants, with some genetic effects unique to each trait.
GWAS Results
Manhattan and regional plots of GWAS results for suggestive associations identified in these 6 IMT phenotypes are shown in Figures 2 and 3 . We did not identify any genome-wide significant SNPs after correcting for the effective number of independent markers tested given observed LD (P=9.9e −8 ) but did detect several suggestive associations. Our strongest associations were with 2 rare variants in complete LD, rs16983261 and rs6113474 (P=1.6e −7 ) with inwIMT, on chromosome 20p11 ( Table 2 ). Both SNPs are intergenic and the closest gene is Paired Box 1 (PAX1). Table 2 presents 23 intronic and intergenic SNPs also associated with internal carotid artery phenotypes at P<5.0e −6 . Suggestive SNPs for internal carotid artery phenotypes were found on chromosome 2q21 with the intronic variant rs13432172 (P=3.9e −7 ) within the gene NCK-associated protein 5 (NCKAP5) and with intergenic SNP rs7157409 (P=4.6e −7 ) on chromosome 14q12. Table 3 summarizes 23 GWAS results for the 3 common carotid artery phenotypes. We found 1 SNP, rs17356664 (P=2.3e −7 ), on chromosome 19q13 that demonstrates suggestive association with cIMT. This variant is also associated (P<0.01e −5 ) with cfwIMT and cnwIMT and is located between the genes exocyst complex component 3-like 2 (EXOC3L2) and microtubule affinity-regulating kinase 4 (MARK4). There was no overlap in genetic association signals between phenotypes for the internal and common carotid arteries at P<1.0×10e −6 . For P<0.001, there are 3 shared SNPs; for P<0.01, 191 shared SNPs (Table II in the online-only Data Supplement); and for P<0.05, there was a total of 3455 shared SNPs between cIMT and iIMT.
The direction of effect for the 6 strongest associations is summarized in Table 4 . In the 2 strongest SNPs (rs17356664 and rs42162) for the common carotid artery, individuals with the minor allele demonstrated higher IMT values than those with the common variant. The opposite occurred for 4 SNPs (rs1342172, rs7157409, rs16983261, and rs6113474) associated with internal carotid artery, where individuals with the minor allele had greatly reduced IMT levels. Of 43 loci ( Table I in . Bottom line, the threshold for suggestive significance (P=5.0e −7 ). Regional plots display inwIMT SNPs demonstrating strongest association ( Table 2 ). LD estimated in the SAFHS sample is shown with rs1342172 on chromosome 2q and rs16983261/rs6113474 on chromosome 20p. IMT indicates intima-media thickness. EFNA5, ESR1, HDAC4, IL-6, MBL2, NOS1, NPR1, PCSK2, PON1, PPARG, RYR3, SH3GL2, TGFB2, TRPM1, and TXNL1) contained nominally significant SNPs in both cIMT and iIMT. The locus with the greatest number of nominally significant SNPs (n=36, P<0.05; n=5, P<0.01) for cIMT was ryanodine receptor 3 (RYR3) located on chromosome 15q14. Even after accounting for potential overlap because of high LD between SNPs r 2 >0.80, multiple nominally significant SNPs remain (n=19, P<0.05; n=5, P<0.01). The locus contained the largest number of nominally significant SNPs for iIMT (n=26, P<0.05; n=9, P<0.01) natriuretic peptide receptor a/guanylate cyclase A (NPR1) on chromosome 1q21. One NPR1 SNP (rs10082235) that had been previously associated with maximum composite IMT in a multiethnic study was included in our analysis but was not significantly associated with iIMT (P=0.98).
Discussion
In a family-based study of Mexican Americans from San Antonio, Texas, we tested 931219 SNPs for genetic association with 6 carotid artery IMT phenotypes (cIMT, cnwIMT, cfwIMT, iIMT, inwIMT, and ifwIMT). As each carotid segment may contain its own anatomy, we chose to analyze each segment individually for genetic variants that may be associated with . Bottom line, the threshold for suggestive significance (P=5.0e −7 ). Regional plots display SNPs demonstrating strongest association (Table 3 ). LD estimated in the SAFHS sample is shown with rs42162 on chromosome 7q and rs17356664 on chromosome 19q. IMT indicates intima-media thickness.
either the near or the far wall of the common and internal carotid arteries. We also analyzed the averaged measure to improve power to detect variants influencing both near and far wall IMT. Using variance-component models corrected for age, sex, lipid medication, and SBP for cIMT, cnwIMT, and cfwIMT; age, sex, lipid medication, and diabetes mellitus for iIMT, inwIMT; and age, sex, diabetes mellitus, and smoking for ifwIMT, we found no genome-wide significant associations (P<9.9e −8 ) that met rigorous correction for multiple testing after accounting for LD within SAFHS participants. The 2 internal carotid artery phenotypes (inwIMT and ifwIMT) were highly genetically correlated (ρ=0.99), indicating that they are influenced by the same underlying genetic components. However, the 2 common IMT phenotypes (cnwIMT and cfwIMT) while genetically correlated (ρ=0.89) with each other may have different underlying genetic mechanisms than the internal IMT measures.
The most strongly associated SNPs (rs16983261 and rs6113474; P=1.6e −7 ) were detected within an intergenic region on chromosome 20p11 for inwIMT. Both SNPs are intergenic and ≈300 kb away from the nearest gene PAX1. This gene is a member of the Pax gene family, which are tissue-specific transcription factors involved in early tissue differentiation. Reduced expression of PAX1 in the vertebral column has been shown to occur in Jarcho-Levin syndrome, which consists of segmentation anomalies of the vertebrae and ribs during fetal development. 31 There were also suggestive associations for internal carotid IMT phenotypes on chromosome 2q21 in the gene NCKAP5 (Nck-associated protein 5; Table 2 ). In mammals, genes belonging to the Nck family have been shown to be common targets for phosphorylation for a variety of growth factor receptors, cell surface antigens, and adhesion molecules 32 Neither PAX1 nor NCKAP5 have been previously associated with internal carotid IMT in other genetic studies.
For common carotid artery phenotypes, the most promising SNP (rs17356664; P=2.3e −7 ) was found upstream of EXOC3L2 on chromosome 19q13, a gene associated with the exocyst complex that mediates directional migration of endothelial cells. 33 This gene has not been previously associated with IMT; however, suggestive association signals for common carotid IMT measurements on chromosome 19q were reported in a recent large meta-GWAS analysis of carotid IMT and plaque in European populations. 20 This meta-analysis detected significant association with the SNP, rs445925 (P=1.7e −8 ), and cIMT Suggestive associations (P<5.0e −7 ) are in bold and displayed in Figure 2 . IMT indicates intima-media thickness; MAF, minor allele frequency; and SNP, singlenucleotide polymorphisms.
*On the basis of National Center for Biotechnology Information reference assembly build 18. †Minor allele is the coded allele. ‡Distance to nearest gene.
upstream of the Apolipoprotein C1 (APOC1) gene on chromosome 19q. This SNP was included in our analysis and was not significant in any of the 6 investigated IMT phenotypes in Mexican Americans. We did, however, find that the APOC1 downstream SNP, rs4420638, was nominally significant with all 3 common carotid artery phenotypes (cIMT P=0.048; cnwIMT P=0.017; cfwIMT P=0.036) but was ≈318 kb away and not in LD with our most significant association signal (rs17356664; P=2.3e −7 ) in the 19q region. This may indicate different variants influencing common carotid IMT between Europeans and Mexican Americans or these SNPs could be tagging an identical rare variant in the same chromosomal region. This 19q13 chromosomal region is also in the same area as the APOE/ C1/CIV/C2 gene complex. 34 The SNP, rs4420638, is known to be in LD with APOE functional variants and in other GWAS has been found to be significant for low-density lipoprotein cholesterol 35, 36 and C-reactive protein. 37, 38 APOC1 is a component of very-low-density lipoprotein and high-density lipoprotein that inhibits very-low-density lipoprotein binding to low-density lipoprotein-related proteins and APOE-mediated binding of very-low-density lipoprotein to the low-density lipoprotein receptor. 34 These findings of suggestive and significant associations in both Europeans and Hispanics in the same chromosome region on 19q are highly indicative that genes in this region impact common carotid IMT. Another variant, rs17398575, identified in the metaanalysis of IMT of Europeans was found on chromosome 7q for carotid arterial plaque in an intergenic region near the gene PIK3CG. 20 This gene encodes a member of the pi3-/pi4-kinase family of proteins. Although our analysis did not include rs17398575, we did identify a SNP, rs42162 (P=5.5e −7 ), in the same intergenic region that demonstrated suggestive association with cIMT. The pi3-/pi4-kinase proteins are important modulators of extracellular signals, including those determined through E-cadherin-mediated cell-to-cell adhesion, and play an important role in endothelin maintenance and structural integrity of epithelia. 20 Other GWAS have also found association in the region for both platelet volume 39 and platelet aggregation 40 suggesting that this region may have important implications for understanding interactions across multiple cardiometabolic traits.
Our results support the hypothesis that underlying biological differences exist between variation in the internal and carotid artery IMT phenotypes (Table I and II in the online-only Data Supplement). Joint analysis of internal and carotid IMT and their genetic correlation within SAFHS families suggested overlapping but not identical genetic components. There were few shared SNPs between the 2 arterial segments and an examination of 43 loci previously suggested to be involved in IMT genetic variation found 7 loci (CACNA2D3, CAPN10, EFNA5, NRP1, RYR3, TRPM1, and TXLN1) to share SNPs with P<0.01 across the 2 carotid arteries. Previous research proposed alternative ultrasound imaging phenotypes differ in their association with traditional CVD risk factors. Specifically, IMT is suggested to result from hypertensive medial hypertrophy and predicted primarily by age and blood pressure. 41 In these SAFHS data, this is certainly the case for common carotid artery IMT which was significantly correlated with SBP and age in polygenic models. Given the potential for collinearity between IMT and SBP, we analyzed our results without SBP. It is not the case that including SBP as a covariate is masking signals and, in fact, association results were weaker when SBP was not included. This does not seem to be the case for internal carotid artery IMT as these phenotypes, while significantly associated with age and diabetes mellitus, were not associated with SBP or diastolic blood pressure. This may further reinforce the previously suggested hypothesis that each arterial segment is influencing different aspects of atherosclerosis with the common carotid artery IMT influencing total atherosclerotic burden and the internal carotid artery IMT more significant in turbulent flow to the brain. 8, 11 This study was conducted in a large well-characterized population-based Hispanic family sample, and IMT measurements were conducted without ascertainment on prior CVD risk. Strengths of this GWAS research are both the number of variants tested along with the substantial heritability estimates of internal carotid artery phenotypes. Despite this study's relatively small sample size (n=772), we were able to independently replicate association results for chromosomal regions on 19q and 7q impacting IMT from a large meta-GWAS analysis of >30 000 individuals, 20 indicating the utility of applying a family-based GWAS approach. These associations are with either intergenic or intronic variants suggesting that they are tagging nearby rare variants that are not well captured by the high-frequency SNPs on GWAS panels. These rare variants may then be responsible for a large portion of the genetic variation in IMT.
Conclusion
To our knowledge, this is the largest GWAS of carotid artery IMT in any non-European population. Although we did not detect any associations that passed rigorous corrections for multiple testing, we identified 3 novel suggestive SNPs on chromosome 19q for common carotid and chromosome 20p for internal carotid artery IMT phenotypes. The detection of susceptibility genes for IMT in the US Hispanic population is important as they have a higher risk of stroke and diabetes mellitus. Therefore, understanding common and rare genetic diversity in this population may allow for discovery of biological pathways involved in the pathogenesis of subclinical atherosclerosis, as well as aid in the early prediction and prevention of CVD and stroke.
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